FDA Grants Breakthrough Device Designation for Whole Genome and Exome Tests
The designation accelerates regulatory review for GeneDx’s ExomeDx and GenomeDx testing platforms designed to diagnose rare diseases.
Read MorePosted by CLP Edit Staff | Oct 27, 2025 | Molecular Diagnostic Analyzers |
The designation accelerates regulatory review for GeneDx’s ExomeDx and GenomeDx testing platforms designed to diagnose rare diseases.
Read MorePosted by CLP Edit Staff | Oct 23, 2025 | Molecular Diagnostic Analyzers |
The upgrade leverages technology by Ultima Genomics and processing at the Gene by Gene lab.
Read MorePosted by CLP Edit Staff | Oct 21, 2025 | Molecular Diagnostics |
A decade-long study shows lower rates of provider-initiated reanalysis among Hispanic, Asian, and Black patients compared with White patients.
Read MorePosted by CLP Edit Staff | Oct 16, 2025 | Library Preparation Systems |
The extraction-free library preparation technology is designed to deliver full transcriptome coverage for drug screening and toxicology studies.
Read MorePosted by Alyx Arnett | Oct 16, 2025 | Disease States |
Researchers say a new blood test can diagnose ME/CFS with 96% accuracy. An expert explains what this means and how close we are to a reliable test.
Read More